
FDA preparing to clear roughly 10 million Johnson & Johnson Covid-19 vaccine doses
CNN
The Food and Drug Administration is preparing to clear two batches of Johnson & Johnson Covid-19 vaccines that were produced at the troubled Emergent facility in Baltimore, a source familiar with the plans told CNN.
This is a significant development, given not a single usable dose of the Johnson & Johnson Covid-19 vaccine from that facility has been approved yet. Around 10 million doses are expected to be included in these batches.More Related News













